Neudle.com: sinemet

Differential
(Click to cross reference)

abdominal protrusion

acetylcholine

acromegaly

adolescent medicine

advances in neurology

adverse drug reaction

affective disorders

akathisia

akinesia of eyelid function

alcohol, neurologic complications with

alcoholism

algorithm

alien hand syndrome

alpha methyldopa hydrazine

amphetamines, dyskinesia associated with

amygdala

anasarca

anemia, iron deficiency

ankle edema

anticholinergic drugs

anticholinergic drugs, side effects of

apraxia of eyelid opening

apraxia, constructional

aprazolam

aqueduct of Sylvius, stenosis

arm swing, reduced

arrhythmia, cardiac

artane

arterial dissection, aorta, cerebral symptoms with

aspartate aminotransferase

aspiration

asterixis

ataxia

attention deficit disorder with hyperactivity

atypical

audiogram

auditory and vestibular pathways

autonomic cardiovascular reflexes

autonomic dysfunction

autonomic dysfunction, evaluation of

autonomic nervous system

axillary nerve

Babinski sign

ballismus, bilateral

basal ganglia, lesion, bilateral

brain transplantation

burst suppression pattern, electroencephalogram

CAT scan, emission, abnormal

catecholamine

catechol-o-methyltransferase inhibitor

cerebral autosomal dominate arteriopathy with subcortical infarction and leukoencephalopathy

cerebral cortical atrophy

cerebral infarction, subcortical

cerebral ischemia

cerebral palsy

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrovascular accident

Charcot's sign

children

chorea

chromosomal abnormality

Clinical Pathologic Conference(C.P.C.)

controversies in neurology

Coombs test, positive

cortical-basal ganglionic degeneration

cyst, arachnoid, infant

dantrolene sodium

degenerative diseases of CNS

dementia, subcortical

dementia, treatment of

deprenyl

depression

desipramine

developmental milestones, loss of

differential diagnosis

dilantin

diplopia

disability rating scale, neurological

disability, neurological

diurnal variation

dopa responsive dystonia

dopamine

dopamine agonist

dopamine receptor

dopamine receptor, D2

drug induced neurologic disorders

dyskinesia, buccal lingual facial

dyskinesia, drug induced

dysphagia

dyspnea

dystonia

dystonia musculorum deformens

dystonia, children

dystonia, etiology of

dystonia, evaluation of

dystonia, focal

dystonia, painful

dystonia, prevalence of

dystonia, symptomatic

dystonia, treatment of

efficacy

electroencephalogram

electroencephalogram, abnormalities of

electroencephalogram, periodic complexes

electroencephalogram, triphasic delta waves

encephalopathy, progressive

epidemiology of neurology

extrapyramidal movement disorder, progressive

eye movement, disorders of

fine motor function, impaired

gamma amino butyric acid

gastrointestinal bleeding

gastrostomy

gaze palsy

gaze palsy, supranuclear

genetic neurologic disorders

genetic screening

genetic testing

Gilles de la Tourette syndrome

hallucination, visual

haloperidol

handwriting

head injury

head injury, brain stem lesion after

head injury, prognosis in

hepatic encephalopathy

hepatic encephalopathy, treatment of

hepatolenticular degeneration(Wilson's disease)

heralding manifestation

Huntington's chorea, presymptomatic detection of

hydrocephalus

hydroxyindole acetic acid 5(5HIAA)

iatrogenic neurologic disorders

inclusion bodies, intranuclear

intranasal medication

L-dopa, controlled release

L-dopa, delayed treatment in Parkinsonism

L-dopa, drug interactions with and side effects of

L-dopa, enteral infusion, continuous

L-dopa, intravenous

L-dopa, liquid

L-dopa, plasma concentration

L-dopa, potentiators of

Lewy body disease, diffuse

limbic system

lisuride

livedo reticularis

liver function enzymes

lobar atrophy

locus ceruleus, lesion of

lorazepam

madopar

manganese intoxication

memory, defect of recent

memory, impairment of

mental status, abnormal

methysergide

metoclopramide

microangiopathy, brain

migraine, treatment of

mimics

misdiagnosis

mitochondrial disease

molecular genetics

monoamine oxidase inhibitors

movement disorder, drug induced

movement disorder, extrapyramidal

movement disorder, treatment of

multiple sclerosis, diet in

multiple sclerosis, treatment of

multiple system atrophy

muscle atrophy, static

myasthenic syndrome, treatment of

neuroleptic malignant syndrome

neuroleptic sensitivity

neuroleptic, atypical

neurologic disease, diagnoses of

neurologic signs

neurologist

neuromyotonia

neuronal degeneration

neuronal intranuclear inclusion disease

neuroophthalmology

neuropathology

neuropathology, brain

neuropathy

neuropathy, peripheral

neuroprotective agents

nigrostriatal pathway

norepinephrine

nortriptyline

obsessive-compulsive disorder

occupational neurologic disorders

ocular myopathy

ocular myopathy, differential diagnosis

olanzapine

old age, neurology of

ondansetron

ophthalmoplegia

oral contraceptives

oral contraceptives, choreiform movements with

orthostatic hypotension

orthostatic hypotension, idiopathic

orthostatic hypotension, treatment of

parasympathetic nervous system

paresthesias

Parkinson disease

Parkinson disease, akinetic form

Parkinson disease, arteriosclerotic

Parkinson disease, axial symptoms

Parkinson disease, complications, late

Parkinson disease, dementia with

Parkinson disease, diagnosis

Parkinson disease, diet restricted in protein

Parkinson disease, differential diagnosis of

Parkinson disease, drug holiday

Parkinson disease, drug induced

Parkinson disease, dystonia with

Parkinson disease, early symptoms

Parkinson disease, etiology of

Parkinson disease, familial

Parkinson disease, fluctuations in

Parkinson disease, freezing phenomena in

Parkinson disease, heterogeneity of

Parkinson disease, juvenile

Parkinson disease, late onset

Parkinson disease, L-dopa nonresponsive

Parkinson disease, misdiagnosis

Parkinson disease, mode of onset

Parkinson disease, nonmotor problems of

Parkinson disease, on-off phenomena in

Parkinson disease, pathogenesis of

Parkinson disease, prognosis of

Parkinson disease, progression

Parkinson disease, rapid progression

Parkinson disease, sensory symptoms in

Parkinson disease, surgical treatment of

Parkinson disease, transient

Parkinson disease, treatment of

Parkinson disease, tremor, absence of

Parkinson disease, wearing off

Parkinson disease, young onset

Parkinsonism multiple-system atrophy

Parkinsonism plus syndrome

Parkinsonism syndrome

paroxetine

parsidol

pathologic gambling

patient information and support

penguin silhouette sign

pergolide

periodic limb movements

periodic movements during sleep

persistent vegetative state

personality change

phenothiazine

phenothiazine, dyskinesia associated with

pregnancy, neurologic complications in

pretectal syndrome

prevention of neurologic disorders

PRKN gene

procyclidine

prognosis

progressive neurologic disorder

progressive supranuclear palsy

psychiatric problems in neurologic disorders

psychological testing, neurologic problems

psychomotor retardation

pure autonomic failure

pyridoxine

pyridoxine deficiency

pyruvate-kinase deficiency anemia

reserpine and reserpine like drugs

respiratory dyskinesias

restless leg syndrome

retrocollis

retropulsion

reversible neurologic disorder

ropinirole, prolonged release

saccadic eye movements, abnormal

scoliosis

seizure

seizure, pyridoxine dependent

selective serotonin reuptake inhibitors

sequencing difficulty

serotonin

serum alanine aminotransferase

short stature

shunt procedure, ventricular-complications of

Shy-Drager syndrome

sinemet

single photon emission computed tomography

skin, biopsy

sleep

sleep pathology and physiology

small vessel disease

solvent

speech disorder

speech disorder, childhood

speech, soft

spinocerebellar ataxia

spinocerebellar ataxia type 1

spinocerebellar ataxia type 2

spinocerebellar ataxia type 3/Machado Joseph disease

Stalevo

stare

status epilepticus

stem cell transplantation

stereotyped behavior

stereotyped behavior, drug induced

stereotypy

steroid therapy, CNS treatment and complications with

stimulation, deep brain

subcortical U fibers

substantia nigra

subthalamic nucleus

subthalamic nucleus deep brain stimulation

sweating

sweating, abnormality of

sympathetic nervous system

sympathomimetic drugs

syncope

synucleinopathy

syphilis, neurologic complications with

toxins, nervous system

trauma

trazodone

treatment of neurologic disorder

tremor, thalamic stimulation for suppression of

tremor, treatment of

tricyclic antidepressant

trigeminal neuralgia

trinucleotide repeats

tripping

twins

tyrosine hydroxylase deficiency

upgaze, paralysis of

urinary incontinence

valium

varicella zoster virus

varicella zoster virus, encephalitis

vertigo, treatment of

vision, blurred

visual impairment

visual symptoms

visuospatial disturbance

walking, difficulty with

white matter disease, subcortical

Showing articles 200 to 233 of 233 << Previous

Successful Use of Bromocriptine in the treatment of a Patient with Chronic Portasystemic Encephalopathy
NEJM 296:793, Morgan,M.Y.,et al, 1977

Juvenile Parkinsonism Treated with Levodopa
Arch Neurol 34:244, Sachdev,K.K.,et al, 1977

Postural Hypotension:Adrenergic Responsivity, & Levodopa Therapy
Neurol 27:921, Corder,C.N.,et al, 1977

Drug Therapy of Parkinsonism
NEJM 295:814, Bianchine,J.R., 1976

Developments in the Treatment of Parkinsonism
NEJM 295:1433, Calne,D.B., 1976

Drugs that Reduce Efficacy of Levodopa
(Letter) , NEJM 295:153876., Hausner,R., 1976

Studies with Bromocriptine Part 2. Double-blind Comparison with Levodopa in Idiopathic Parkinsonism
Neurol 26:511, Kartzinel,R.,et al, 1976

Treatment of Parkinson's Disease with Bromocriptine
NEJM 295:1400, Lieberman,A.,et al, 1976

Narcolepsy:REM Sleep Suppression by L-Dopa, (Letter)
NEMJ 294:849, Gilbert,J.C.,et al, 1976

Huntington's Chorea-Deficiency of Y-Aminobutynic Acid in Brain
NEJM 288:337, 1973, 289:104, 1973, 292:10295., Perry,T.,et al, 1975

Important Advances in Clinical Medicine
West J Med 123:128, Mosier,J.M.,et al, 1975

Progressive Supranuclear Palsy-Case Study
NEJM 293:346, Richardson,E.P., 1975

Catecholamines & Neurologic Diseases
NEJM 293:274, Moskowitz,M.A.,et al, 1975

Levodopa-Induced Myoclonus
Arch Neurol 32:331-334, Klawans,H.L., 1975

Prolonged Levodopa Therapy
BMJ 383, Feb 1973., , 1973

Drug Therapy of Parkinsonism
NEJM 287:20, Yahr,M.,et al, 1972

Treatment of Parkinsonism
NEJM 287:1047, Young,R.R., 1972

Metabolic Responses to Acute & Chronic L-Dopa Administration in Patients with Parkinsonism
NEJM 287:729, Sirtori,C.,et al, 1972

Treatment for Parkinsonism
Other than Levodopa, BMJ 741, 1972 March., , 1972

Occurence of Positive Coombs Test in Patients Treated with Levodopa
NEJM 286:1401, Joseph,C., 1972

Methyldopahydrazine as an Adjunct to L-Dopa Therapy in Parkinsonism
Neurol 22:384, Chase,T.,et al, 1972

Modern Treatment of Parkinson's Disease
Excerpta Medica, 2:1972 Sept., , 1972

Implications of Amphetamine-Induced Stereotyped Behavior as a Model for Tardive Dyskinesias
Arch Gen Psychiat 27:502-507, Rubovits,R.,et al, 1972

Presymptomatic Detection of Huntington's Chorea
BMJ 540, 1972 Sept., , 1972

Use of L-Dopa in the Detection of Presymptomatic Huntington's Chorea
NEJM 286:1332, Klawans,H.,et al, 1972

Levodopa Therapy:Why Wait? Patient Care June 15
1971., , 1971

Manic Response to Levodopa Therapy
NEJM 285:788, Ryback,R.,et al, 1971

Drug-Induced Movement Disorders
Postgrad Med 180, 1971, Sept., North,R., 1971

Combined Treatment of Parkinsonian Tremor with Propranolol & Levodopa
J Neurol Sci 14:491, , 1971

Modern Treatment of Parkinson's Disease
Excerpta Medica l:Nov-Dec, , 1971

Modern Treatment of Parkinson's Disease
Excerpta Medica 2:1971 Oct., , 1971

How does L-Dopa Work in Parkinsonism
Lancet 784, 1971 Apr., Sandler,M., 1971

Monoamine Oxidase Inhibitor & L-Dopa
BMJ 3:388, Hunter,H.R.,et al, 1970

L-Dopa in the Treatment of Parkinson's Disease
Postgrad Med 47:153, Martin,W., 1970

Showing articles 200 to 233 of 233 << Previous